ClinicalTrials.govpublic full text
Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5
end-stage renal disease, stage 5 chronic kidney disease, telavancin, esrd, pharmacokinetics, hemodialysis, chronic kidney disease, ckd, dialysis, vibativ, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 892637
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.